Pharmacokinetics, Bioavailability, and Metabolism of Zongertinib, a Novel HER2‐Selective Tyrosine Kinase Inhibitor, in Rat by Liquid Chromatography Hyphenated With Electrospray Ionization Tandem Mass Spectrometry
Year: 2026
Type: article
Source: Biomedical Chromatography
DOI: 10.1002/bmc.70434
Authors: Wenfei Sun, Fang Wang, Furui Chu, Zheheng Ma
Institution: Xuzhou Central Hospital
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7140617135
